ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Multicenter Assessment of ALD403 in Chronic Migraine

ClinicalTrials.gov ID: NCT02275117

Public ClinicalTrials.gov record NCT02275117. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Dose-Ranging Phase 2 Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of ALD403 Administered Intravenously in Patients With Chronic Migraine

Study identification

NCT ID
NCT02275117
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alder Biopharmaceuticals, Inc.
Industry
Enrollment
665 participants

Conditions and interventions

Interventions

  • ALD403 Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2014
Primary completion
Feb 29, 2016
Completion
Oct 31, 2016
Last update posted
Apr 7, 2020

2014 – 2016

United States locations

U.S. sites
82
U.S. states
30
U.S. cities
78
Facility City State ZIP Site status
Research Site Huntsville Alabama 35801
Research Site Mobile Alabama 36608
Research Site Phoenix Arizona 85027
Research Site Scottsdale Arizona 85259
Research Site Hot Springs Arkansas 71901
Research Site Little Rock Arkansas 72211
Research Site Anaheim California 92801
Research Site Encino California 91436
Reserach Site Long Beach California 90806
Research Site Los Angeles California 90036
Research Site Oakland California 94612
Research Site San Diego California 92108
Research Site San Francisco California 94102
Research Site Santa Monica California 90404
Research Site Stanford California 94305
Research Site Ventura California 93003
Research Site Colorado Springs Colorado 80918
Research Site Denver Colorado 80210
Research Site Stamford Connecticut 06905
Research Site Waterbury Connecticut 06708
Research Site Gainesville Florida 32607
Research Site Hallandale Florida 33009
Research Site Jacksonville Florida 32256
Research Site Miami Florida 33144
Research Site Miami Florida 33173
Research Site North Miami Florida 33161
Research Site Orlando Florida 32801
Research Site Orlando Florida 32806
Research Site Tampa Florida 33606
Research Site Atlanta Georgia 30022
Research Site Atlanta Georgia 30342
Research Site Chicago Illinois 60607
Research Site Chicago Illinois 60640
Research Site Evansville Illinois 47714
Research Site Normal Illinois 61761
Research Site Prairie Village Kansas 66206
Research Site Wichita Kansas 67207
Research Site Louisville Kentucky 40207
Research Site New Orleans Louisiana 70115
Research Site Shreveport Louisiana 71105
Research Site Boston Massachusetts 21310
Research Site Brockton Massachusetts 02301
Research Site New Bedford Massachusetts 02740
Research Site Watertown Massachusetts 02472
Research Site Ann Arbor Michigan 48104
Research Site Springfield Missouri 65807
Research Site St Louis Missouri 63141
Research Site Omaha Nebraska 68134
Research Site Princeton New Jersey 08540
Research Site Albuquerque New Mexico 87102
Research Site Albany New York 12208
Research Site Amherst New York 14226
Research Site Brooklyn New York 11235
Research Site Endwell New York 13760
Research Site New York New York 10019
Research Site Rochester New York 14609
Research Site The Bronx New York 10461
Research Site Cary North Carolina 27518
Research Site Winston-Salem North Carolina 27103
Research Site Canton Ohio 44718
Research Site Cincinnati Ohio 45255
Research Site Cleveland Ohio 44195
Research Site Columbus Ohio 43213
Research Site Dayton Ohio 45424
Research Site Oklahoma City Oklahoma 73116
Research Site Portland Oregon 97239
Research Site Philadelphia Pennsylvania 19107
Research Site Willow Grove Pennsylvania 19090
Research Site Mt. Pleasant South Carolina 29464
Research Site Chattanooga Tennessee 37421
Research Site Memphis Tennessee 38119
Research Site Austin Texas 78705
Research Site Dallas Texas 75231
Research Site Fort Worth Texas 76104
Research Site Houston Texas 77058
Research Site Orem Utah 84058
Research Site Salt Lake City Utah 84109
Research Site Richmond Virginia 23226
Research Site Virginia Beach Virginia 23454
Research Site Bellevue Washington 98007
Research Site Seattle Washington 98105
Research Site Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02275117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2020 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02275117 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →